- Home
- OCC vs TENX Comparison
OCC vs TENX Comparison
Compare OCC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCC | TENX |
|---|---|---|
| Founded | 1983 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 56.2M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | OCC | TENX |
|---|---|---|
| Price | $4.23 | $17.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 148.6K | ★ 261.3K |
| Earning Date | 12-18-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $73,038,213.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.54 | N/A |
| 52 Week Low | $2.40 | $4.63 |
| 52 Week High | $11.50 | $15.58 |
Technical Indicators
Market Signals| Indicator | OCC | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 33.76 | 80.64 |
| Support Level | $4.04 | $11.06 |
| Resistance Level | $4.60 | $14.02 |
| Average True Range (ATR) | 0.35 | 1.29 |
| MACD | 0.05 | 0.33 |
| Stochastic Oscillator | 30.68 | 95.32 |
Price Performance
Historical ComparisonAbout OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.